These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 9432019)

  • 1. Selective enrichment in human megakaryocyte progenitors by the B203.13 surface differentiation antigen.
    Vitale M; Zauli G; Bassini A; Visani G; Rezzani R; Croce CM; Manzoli FA
    Br J Haematol; 1997 Dec; 99(4):766-9. PubMed ID: 9432019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferative properties of human umbilical cord blood megakaryocyte progenitor cells to human thrombopoietin.
    Hagiwara T; Kodama I; Horie K; Kato T; Miyazaki H
    Exp Hematol; 1998 Mar; 26(3):228-35. PubMed ID: 9502619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel surface marker (B203.13) of human haemopoietic progenitors, preferentially expressed along the B and myeloid lineages.
    Zamai L; Vitale M; Bennett IM; Croce CM; Perussia B
    Br J Haematol; 1998 Sep; 102(4):965-75. PubMed ID: 9734647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of thrombopoietin on the proliferation and differentiation of primitive and mature haemopoietic progenitor cells in cord blood.
    Schipper LF; Brand A; Reniers NC; Melief CJ; Willemze R; Fibbe WE
    Br J Haematol; 1998 Jun; 101(3):425-35. PubMed ID: 9633882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human megakaryocytes. V. Changes in the phenotypic profile of differentiating megakaryocytes.
    Levene RB; Lamaziere JM; Broxmeyer HE; Lu L; Rabellino EM
    J Exp Med; 1985 Mar; 161(3):457-74. PubMed ID: 3973535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human mesenchymal stem cells support megakaryocyte and pro-platelet formation from CD34(+) hematopoietic progenitor cells.
    Cheng L; Qasba P; Vanguri P; Thiede MA
    J Cell Physiol; 2000 Jul; 184(1):58-69. PubMed ID: 10825234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD226 is expressed on the megakaryocytic lineage from hematopoietic stem cells/progenitor cells and involved in its polyploidization.
    Ma D; Sun Y; Lin D; Wang H; Dai B; Zhang X; Ouyang W; Jian J; Jia W; Xu X; Jin B
    Eur J Haematol; 2005 Mar; 74(3):228-40. PubMed ID: 15693793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of amifostine on the proliferation and differentiation of megakaryocytic progenitor cells.
    Kashiwakura I; Murakami M; Inanami O; Hayase Y; Takahashi TA; Kuwabara M; Takagi Y
    Eur J Pharmacol; 2002 Feb; 437(1-2):19-25. PubMed ID: 11864634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combination of megakaryocyte growth and development factor and interleukin-1 is sufficient to culture large numbers of megakaryocytic progenitors and megakaryocytes for transfusion purposes.
    van den Oudenrijn S; de Haas M; Calafat J; van der Schoot CE; von dem Borne AE
    Br J Haematol; 1999 Aug; 106(2):553-63. PubMed ID: 10460622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CD41 and c-mpl does not indicate commitment to the megakaryocyte lineage during haemopoietic development.
    Basch RS; Zhang XM; Dolzhanskiy A; Karpatkin S
    Br J Haematol; 1999 Jun; 105(4):1044-54. PubMed ID: 10554819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombopoietin is synergistic with other cytokines for expansion of cord blood progenitor cells.
    Won JH; Cho SD; Park SK; Lee GT; Baick SH; Suh WS; Hong DS; Park HS
    J Hematother Stem Cell Res; 2000 Aug; 9(4):465-73. PubMed ID: 10982244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
    Siena S; Bregni M; Bonsi L; Sklenar I; Bagnara GP; Bonadonna G; Gianni AM
    Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enrichment and characterization of peripheral blood-derived megakaryocyte progenitors that mature in short-term liquid culture.
    Nichol JL; Hornkohl AC; Choi ES; Hokom MM; Ponting I; Schuening FW; Hunt P
    Stem Cells; 1994 Sep; 12(5):494-505. PubMed ID: 7528590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a liquid culture system for megakaryocyte terminal differentiation: fibrinogen promotes megakaryocytopoiesis but not thrombopoiesis.
    Sato T; Ono M; Fujita H; Tanaka N; Tomiyama J; Sakamoto Y; Takano Y; Murota SI; Morita I
    Br J Haematol; 2003 Apr; 121(2):315-23. PubMed ID: 12694255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of human megakaryocytes derived from pure megakaryocytic colonies (CFU-M), megakaryocytic-erythroid colonies (CFU-M/E), and mixed hemopoietic colonies (CFU-GEMM) by antibodies against platelet associated antigens.
    Kanz L; Straub G; Bross KG; Fauser AA
    Blut; 1982 Oct; 45(4):267-74. PubMed ID: 7126882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo expansion of early and late megakaryocyte progenitors.
    Lefebvre P; Winter JN; Meng Y; Cohen I
    J Hematother Stem Cell Res; 2000 Dec; 9(6):913-21. PubMed ID: 11177605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating megakaryocyte progenitors in myeloproliferative disorders are hypersensitive to interleukin-3.
    Kobayashi S; Teramura M; Hoshino S; Motoji T; Oshimi K; Mizoguchi H
    Br J Haematol; 1993 Apr; 83(4):539-44. PubMed ID: 7686030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced expansion and maturation of megakaryocytic progenitors by fibronectin.
    Han P; Guo XH; Story CJ
    Cytotherapy; 2002; 4(3):277-83. PubMed ID: 12194724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of flt-3 ligand in combination with TPO on the expansion of megakaryocytic progenitors.
    Li K; Yang M; Lam AC; Yau FW; Yuen PM
    Cell Transplant; 2000; 9(1):125-31. PubMed ID: 10784074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.